XENADRINE STUDIES

Eastern Michigan University Study,
published in the Journal of Exercise Physiology online (May 2001)

In a new, independent, double blind, placebo controlled, product-specific clinical study, conducted at Eastern Michigan University, 20 obese individuals (15 women, 5 men) were equally divided into two groups: the placebo group and the Xenadrine group. The subjects were matched according to age, gender, height, weight and body-fat, and were randomly assigned to receive either Xenadrine or the placebo.

At the conclusion of the six-week study, the Xenadrine test subjects had safely lost 524% more total fat and 759% more weight than the placebo group. These numbers are even more impressive when you consider that at the same time they were losing the fat, the Xenadrine group actually gained 61% more lean body mass. Adding to these convincing results is the fact that both groups endured minimal exercise. And, the placebo group consumed less fat in their daily diet than the Xenadrine group.

The researchers postulated that had the placebo group consumed the identical amount of fat as the Xenadrine group, Xenadrine’s effectiveness would have been even more dramatic. In addition, these remarkable effects were obtained despite no significant changes in the Xenadrine groups’ eating habits over the course of the study. In other words, these substantial decreases in body-fat and total body weight, and gains in lean mass were all obtained from Xenadrine without reducing their food intake.

Conclusion: Xenadrine supplementation caused statistically significant decreases in the percentage of fat, fat mass and overall body weight compared to placebo.

These overall results more than support the findings of the earlier clinical study (see below) confirming Xenadrine’s unprecedented effectiveness as a thermogenic weight-loss supplement.

The original Xenadrine study, published in Current Therapeutic Research (April 2000)

In a landmark, double blind, placebo-controlled, independent clinical study, 30 subjects of similar age, sex, weight, health, and body type were randomly divided into two groups: the Xenadrine group and the placebo group. All test subjects underwent a monitored, cross-training exercise program three days per week and consumed the same amount of calories per day.

Once the eight-week study was concluded, the researchers found that Xenadrine safely increased the rate of fat-loss by a phenomenal 38.6 times more than the placebo group. Never before had a natural product been documented to stimulate fat loss of this extraordinary magnitude. Xenadrine also reduced test subject’s total body-weight and yielded significant muscle-sparring effects, which left the subjects significantly leaner and more toned. The results proved so impressive that they were published in the prestigious journal, Current Therapeutic Research and presented at the annual conference of the North American Association for the Study of Obesity.

While other companies rely on generic research that has little to do with their particular product, Xenadrine, from Cytodyne Technologies, is the only diet supplement proven effective in two separate, independent, product-specific, double blind clinical studies.

These groundbreaking clinical studies help to explain why so many researchers consider Xenadrine to be the greatest fat-loss discovery in the history of diet supplements.